G-Protein Coupled Receptors (GPCRs): A Potential Target of Apigenin As a Novel HACE2 Receptor Specific Therapeutic for Impeding Lung Cancer Considering a Group of Missense and Nonsense Mutations in COVID-19 Patients. EJPHARMA 2025, 5 (1), 6-15. https://doi.org/10.24018/ejpharma.2025.5.1.85.